References

  1. UNAIDS. UNAIDS report on the global AIDS epidemic 2013. Geneva: www.UNAIDS.org; 2013. Visité le 25 Avril 2016. Google Scholar

  2. OMS. Vers un accès universel. Étendre les interventions prioritaires liées au VIH/SIDA dans le secteur de la santé. Rapport de situation 2008. Geneva: http://www.who.int/hiv/pub/towards_universal_access_report_2008_fr.pdf; 2008. Visité le 25 Avril 2016. Google Scholar

  3. Caron M, Lekana-Douki SE, Makuwa M, Obiang-Ndong GP, Biba O, Nkoghe D et al. Prevalence, genetic diversity and antiretroviral drugs resistance-associated mutations among untreated HIV-1-infected pregnant women in Gabon, central Africa. BMC infectious diseases. 2012;12:64. PubMed | Google Scholar

  4. Mombo LE, Bisseye C, Mickala P, Ossari S, Makuwa M. Genotyping of CCR5 gene, CCR2b and SDF1 variants related to HIV-1 infection in Gabonese subjects. Intervirology. 2015;58(1):22-6. PubMed | Google Scholar

  5. PNL-IST-VIH/SIDA. Guide de prise en charge des personnes vivant avec le VIH et le SIDA au Gabon. Libreville: Ministère de la Santé, Édition 2014; 2014. Google Scholar

  6. OMS. Antiretroviral therapy for HIV infection in adults and adolescents. Geneva: http://www.who.int/hiv/pub/guidelines/adult/en/; 200 Visité le 25 Avril 2016. Google Scholar

  7. OMS. Antiretroviral therapy for HIV infection in adults and adolescents. Geneva: http://www.who.int/hiv/pub/arv/adult2010/en/; 2010. Google Scholar

  8. OMS. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva: http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.pdf; 2013. Visité le 25 Avril 2016. Google Scholar

  9. Okome Nkoumou MML, Okome Essima R, Obiang Ndong GP, Okome Miame F. Bilan clinico-biologique des patients infectés par le VIH à la fondation jeanne EBORI de Libreville (2002-2005). Med Trop. 2007; 67(4):357-62. PubMed | Google Scholar

  10. Moore DM, Yiannoutsos CT, Musick BS, Tappero J, Degerman R, Campbell J et al. Determinants of early and late mortality among HIV-infected individuals receiving home-based antiretroviral therapy in rural Uganda. Journal of acquired immune deficiency syndromes. 2011;58(3):289-96. PubMed | Google Scholar

  11. Bekolo CE, Webster J, Batenganya M, Sume GE, Kollo B. Trends in mortality and loss to follow-up in HIV care at the Nkongsamba Regional hospital, Cameroon. BMC research notes. 2013;6:512. PubMed | Google Scholar

  12. Kone MC, Cissoko Y, Diallo MS, Traore BA, Malle KK. [Epidemiological, clinical and therapeutics' data of HIV-infected patients placed on ART in the Segou hospital in Mali (2004-2011)]. Bulletin de la Societe de pathologie exotique. 2013;106(3):176-9. PubMed | Google Scholar

  13. Aliyu MH, Blevins M, Parrish DD, Megazzini KM, Gebi UI, Muhammad MY et al. Risk factors for delayed initiation of combination antiretroviral therapy in rural north central Nigeria. Journal of acquired immune deficiency syndromes. 2014;65(2):e41-9. PubMed | Google Scholar

  14. Caron M, Makuwa M, Souquière S, Descamps D, Brun-Vézinet F, Kazanji M. Human immunodeficiency virus type 1 seroprevalence and antiretroviral drug resistance-associated mutations in miners in Gabon, central Africa. AIDS Res Hum Retroviruses. 2008 Sep;24(9):1225-8. PubMed | Google Scholar

  15. Bashi J, Balestre E, Messou E, Maiga M, Coffie PA, Zannou DM et al. [Time trends in demographic and clinical characteristics of adult patients on HAART initiation in West Africa]. Medecine et maladies infectieuses. 2010;40(8):449-55. PubMed | Google Scholar

  16. Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, Miotti P et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006;367(9513):817-24. PubMed | Google Scholar

  17. Calmy A, Pinoges L, Szumilin E, Zachariah R, Ford N, Ferradini L et al. Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. Aids. 2006;20(8):1163-9. PubMed | Google Scholar

  18. Sieleunou I, Souleymanou M, Schonenberger AM, Menten J, Boelaert M. Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon. Tropical medicine& international health, TM & IH. 2009;14(1):36-43. PubMed | Google Scholar

  19. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS medicine. 2007;4(10):e298. PubMed | Google Scholar

  20. Egger M, Spycher BD, Sidle J, Weigel R, Geng EH, Fox MP et al. Correcting mortality for loss to follow-up: a nomogram applied to antiretroviral treatment programmes in sub-Saharan Africa. PLoS medicine. 2011;8(1):e1000390. PubMed | Google Scholar

  21. Fox MP, Shearer K, Maskew M, Macleod W, Majuba P, Macphail P et al. Treatment out comes after 7 years of public-sector HIV treatment. Aids. 2012;26(14):1823-8. PubMed | Google Scholar

  22. Marazzi MC, Liotta G, Germano P, Guidotti G, Altan AD, Ceffa S et al. Excessive earlymortality in the first year of treatment in HIV type 1-infected patients initiating antiretroviral therapy in resource-limited settings. AIDS research and human retroviruses. 2008;24(4):555-60. PubMed | Google Scholar

  23. Cornell M, Schomaker M, Garone DB, Giddy J, Hoffmann CJ, Lessells R et al. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicenter cohort study. PLoS medicine. 2012;9(9):e1001304. PubMed | Google Scholar